Robert W. Milne
Adelaide, SA 5001, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Cell-cycle targeted cancer therapy: clinical advances, biological gaps, and the emergence of selective CDK4 inhibitors.
Journal: Journal of hematology & oncology
Published: February 03, 2026
A brain-penetrant CDK4/6 inhibitor - AU3-14 shows robust anti-tumor efficacy against glioblastoma.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 05, 2025
Liposomal 5-Fluorouracil Polymer Complexes Facilitate Tumor-Specific Delivery: Pharmaco-Distribution Kinetics Using Microdialysis.
Journal: Pharmaceutics
Published: December 23, 2021
Erratum to "A first-in-class CDK4 inhibitor demonstrates in vitro, ex-vivo and in vivo efficacy against ovarian cancer" [Gynecologic Oncology 159 (2020) 827-838].
Journal: Gynecologic oncology
Published: August 03, 2021
CDK9: A Comprehensive Review of Its Biology, and Its Role as a Potential Target for Anti-Cancer Agents.
Journal: Frontiers in oncology
Published: March 09, 2021
Potent and orally bioavailable CDK8 inhibitors: Design, synthesis, structure-activity relationship analysis and biological evaluation.
Journal: European journal of medicinal chemistry
Published: December 21, 2020
Sulfonamide-Based Inhibitors of Biotin Protein Ligase as New Antibiotic Leads.
Journal: ACS chemical biology
Published: August 14, 2019
Bioanalysis and Stability of Polymyxins.
Journal: Advances in experimental medicine and biology
Published: August 01, 2019
Discovery of CDK5 Inhibitors through Structure-Guided Approach.
Journal: ACS medicinal chemistry letters
Published: January 29, 2019
Discovery of N-Phenyl-4-(1H-pyrrol-3-yl)pyrimidin-2-amine Derivatives as Potent Mnk2 Inhibitors: Design, Synthesis, SAR Analysis, and Evaluation of in vitro Anti-leukaemic Activity.
Journal: Medicinal chemistry (Shariqah (United Arab Emirates))
Published: October 04, 2018
Last Updated: 09/26/2026